News
November 29, 2010 – Independent research firm Frost and Sullivan has given TeraRecon the North American Growth Leadership of the Year award in Advanced Visualization and Clinical Applications. This is the sixth time in the past 10 years that Frost and Sullivan has given the company an award. The company also received the European Company of the Year award for medical imaging.
November 28, 2010
Technology
November 24, 2010 – A new advanced visualization and analysis software suite has passed a detailed evaluation and testing process and is now available for sale. The Vitrea Enterprise Suite version 6.0, from Vital Images, has achieved VMware Ready status and is now listed on the VMware Partner Product Catalog.
November 24, 2010
News
November 24, 2010 – Data from the PICTURE trial showed that an insertable cardiac monitor led to diagnosis and treatment for 78 percent of patients who experienced a recurrent syncopal (fainting) event during the study. The Reveal family of insertable cardiac monitors, by Medtronic, also showed that 75 percent of those diagnosed were shown to have a cardiac cause of their syncopal event.
November 24, 2010Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025
News
November 24, 2010 – Results for a trial comparing a drug-eluting stent to balloon angioplasty and bare metal stenting in treating restenosis after angioplasty were announced at the VEITHsymposium. The Zilver PTX drug-eluting stent met the trial's 12-month primary endpoints. The stent has CE mark approval in Europe for the superficial femoral artery.
November 24, 2010News
November 24, 2010 – Researchers at Northwestern are utilizing a patient’s own stem cells to regenerate heart and vascular tissue, offering a potential new treatment for cardiovascular disease. Northwestern Medicine is the lead site for a study examining stem cell transplantation as treatment for critical limb ischemia.
November 24, 2010
News
November 24, 2010 – Cardiologists and primary care physicians now perceive AstraZeneca's Crestor as comparable to Pfizer’s Lipitor in treating and reducing mortality in dyslipidemia patients, according to a survey by Decision Resources. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better.
November 24, 2010Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
November 24, 2010 - Rotational computed tomography angiography (CTA), a new noninvasive imaging modality, has the ability to display angiography in 3-D formats. This allows for considerable simplification of orientation of complex fenestrated/branched stent grafts in 3-D views, as well as catheterization of target vessels.
November 24, 2010News
November 23, 2010 - The preliminary findings of the CREST study have so far failed to squelch the debate between proponents of the two different interventions for preventing stroke in patients with carotid stenosis. And at least one prominent vascular surgeon sees a most-unscientific phenomenon - “presenter bias” - as one reason the controversy is likely to continue.
November 23, 2010News
November 23, 2010 – Boston Scientific will acquire Sadra Medical, a development-stage company in Los Gatos, Calif. Boston Scientific will pay $193 million up front, plus potential payments of up to $193 million upon achievement of specified regulatory and revenue-based milestones through 2016. The transaction is expected to be completed in the fourth quarter 2010 or early 2011.
November 23, 2010Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
November 23, 2010 – A device for peripheral transluminal angioplasty (PTA) and for capturing and containing embolic material during angioplasty in the lower extremities has been approved by the U.S. Food and Drug Administration (FDA). The Proteus device, by Angioslide, can be used in the femoral, iliac, iliofemoral, popliteal, tibial, peroneal and profunda arteries.
November 23, 2010News
November 23, 2010 – Study results found significant differences in men and women older than 80 who underwent carotid surgical incision and carotid artery angioplasty and stenting. The results were presented by Caron B. Rockman, M.D., associate professor of surgery at the New York University School of Medicine at the VEITHsymposium.
November 23, 2010
News
November 23, 2010 - A new technique that combines the heat and energy of ultrasound with the highly targeted delivery of clot-busting drugs appears to be effective at treating patients with acute massive pulmonary embolism (PE). The new treatment, called ultrasound-accelerated catheter-directed thrombolysis (CDT), was developed by the Ekos Corporation.
November 23, 2010Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024Technology
Exam-Link is a regional health information organization (RHIO) image-sharing platform from CoActiv. The LINK provides ...
November 22, 2010News
November 22, 2010 – At the VEITHsymposium, physicians debated whether stents are usually required in the endovenous treatment of chronic venous disease. Seshadri Raju M.D., professor emeritus of surgery at the University of Mississippi Medical Center in Flowood, Miss., said that detectable iliac vein stenosis is present in more than 90 percent of cases of chronic venous disease (CVD).
November 22, 2010News
November 22, 2010 – A new whole-body, integrated magnetic resonance imaging/positron emission tomography (MRI/PET) system is capable of simultaneous data acquisition.
November 22, 2010